detail
The conference brings together international experts to explore how digital health and AI can enhance early cancer screening while optimizing the reimbursement and affordability of precision medicine.
It focuses on aligning Taiwan’s “Healthy Taiwan” initiative with global trends to foster multilateral partnerships, bridge gaps in treatment equity, and reduce the global burden of cancer.
Forum 1
Cancer Policy and Innovation :
From Early Detection to Equitable Treatment
May 18, 2026, 02:00 PM – 05:00 PM
Overview
Cancer remains one of the leading causes of death and a profound global health burden, contributing to approximately 10 million deaths in 2020. A significant proportion of cancers can be effectively managed or cured if detected early and treated promptly. Consequently, scaling up early screening, advancing innovative therapies, and leveraging AI technologies have emerged as pivotal policy imperatives worldwide, alongside strategic efforts to address systemic barriers to treatment accessibility and affordability.
In Taiwan, cancer has persistently been the leading cause of death for the past 43 years, resulting in more than 50,000 deaths annually and placing a heavy burden on individuals, families, and society. Under the “Healthy Taiwan” initiative, Taiwan has launched the “Three Pillars of Cancer Treatment of Cancer Control”: Early detection through screening, Genetic testing and Precision medicine analysis, and establishing a dedicated Cancer Drug Fund. These measures aim to enhance patients access to high-value care and optimize reimbursement mechanisms, thereby advancing timely, equitable, and affordable cancer prevention and treatment.
Against the backdrop of the 79th World Health Assembly, Taiwan’s Ministry of Health and Welfare (MOHW) will convene international experts to exchange policy practices and innovative experiences, with the goal of fostering early detection, equitable treatment, and multilateral collaboration. The forum will explore critical themes, including: enhancing the coverage and quality of cancer screening via digital health innovations; optimizing reimbursement and affordability of precision and innovative therapies; and building more comprehensive international partnerships to bridge the gap in cancer health equity. Through this high-level dialogue, we aim to catalyze collective action to alleviate the global cancer burden and secure a healthier future for all.
Forum 2
Global Hepatitis C Elimination :
Experience and the Road Ahead
May 19, 2026, 09:00 AM – 12:00 PM
Overview
The World Health Organization (WHO) has charted an ambitious mandate to eliminate viral hepatitis as a public health threat by 2030. Despite significant global strides, Hepatitis B and C continue to impose a staggering burden on global health systems, with systemic disparities in diagnosis and treatment access remaining a critical barrier to achieving universal health equity.
In proactive alignment with these global priorities, Taiwan has spearheaded the “Taiwan Hepatitis C Policy Guideline 2018-2025.” This framework is anchored by three core strategies:
“Precision Public Health,” “Localized Care Delivery,” and an “Continuum of Care.” This approach is further operationalized through a synergistic policy triad: “Therapy Spearheads Prevention,” “Screening Supports Therapy,” and “Prevention Secures Outcomes.”
Through these rigorous interventions, Taiwan successfully reached its elimination targets in 2025, attaining this milestone five years ahead of the WHO’s 2030 schedule. Taiwan’s national performance has surpassed the WHO Path to Elimination “Gold Tier” standards, maintaining diagnosis and treatment rates exceeding 90% while achieving 100% coverage in injection safety and blood screening efficacy.
Against the backdrop of the 79th World Health Assembly, the Ministry of Health and Welfare (MOHW), Taiwan, will convene a high-level strategic forum to catalyze multilateral knowledge exchange among international experts and stakeholders. This event serves as a premier platform to synthesize transformative health models and collectively navigate the complexities of the post-elimination landscape.
The forum will feature a comprehensive exploration of scalable success stories and the pivotal role of civil society, while addressing the strategic imperatives of maintaining sustainability in the post-elimination era. By synergizing national and international action plans toward 2030, we aim to provide a decisive contribution to the worldwide mission of securing a hepatitis-free future.
We cordially invite the global health community to join us in this critical dialogue as we
re-affirm our unwavering commitment to global health security.
